↓ Skip to main content

American Association for Cancer Research

Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo

Overview of attention for article published in Molecular Cancer Therapeutics, January 2009
Altmetric Badge

Mentioned by

patent
107 patents

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
44 Mendeley
Title
Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo
Published in
Molecular Cancer Therapeutics, January 2009
DOI 10.1158/1535-7163.mct-08-0149
Pubmed ID
Authors

Renate Burger, Steven Le Gouill, Yu-Tzu Tai, Reshma Shringarpure, Pierfrancesco Tassone, Paola Neri, Klaus Podar, Laurence Catley, Teru Hideshima, Dharminder Chauhan, Eian Caulder, Claire L. Neilan, Kris Vaddi, Jun Li, Martin Gramatzki, Jordan S. Fridman, Kenneth C. Anderson

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 1 2%
Unknown 43 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 18%
Researcher 8 18%
Other 4 9%
Professor > Associate Professor 4 9%
Professor 3 7%
Other 9 20%
Unknown 8 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 13 30%
Medicine and Dentistry 10 23%
Biochemistry, Genetics and Molecular Biology 2 5%
Immunology and Microbiology 2 5%
Nursing and Health Professions 1 2%
Other 5 11%
Unknown 11 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2024.
All research outputs
#7,727,332
of 23,495,502 outputs
Outputs from Molecular Cancer Therapeutics
#1,714
of 3,914 outputs
Outputs of similar age
#50,081
of 173,188 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#19
of 36 outputs
Altmetric has tracked 23,495,502 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,914 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,188 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.